A new trading day began on Tuesday, with Senti Biosciences Inc (NASDAQ: SNTI) stock price down -4.92% from the previous day of trading, before settling in for the closing price of $1.22. SNTI’s price has ranged from $1.15 to $5.10 over the past 52 weeks.
Meanwhile, its annual earnings per share averaged 78.01%. With a float of $6.79 million, this company’s outstanding shares have now reached $26.29 million.
Considering the fact that the conglomerate employs 34 people, you should pay attention to its efficiency factor.
Senti Biosciences Inc (SNTI) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Senti Biosciences Inc is 74.16%, while institutional ownership is 6.98%. The most recent insider transaction that took place on Feb 04 ’25, was worth 15,963. In this transaction CEO of this company sold 3,922 shares at a rate of $4.07, taking the stock ownership to the 82,627 shares. Before that another transaction happened on Feb 06 ’25, when Company’s CEO sold 545 for $4.36, making the entire transaction worth $2,376. This insider now owns 82,082 shares in total.
Senti Biosciences Inc (SNTI) Recent Fiscal highlights
In its latest quarterly report, released on 12/31/2024, the company reported earnings of -0.67 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.53 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 78.01% per share during the next fiscal year.
Senti Biosciences Inc (NASDAQ: SNTI) Trading Performance Indicators
Here are Senti Biosciences Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 1.51.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.34, a number that is poised to hit -0.41 in the next quarter and is forecasted to reach -1.41 in one year’s time.
Technical Analysis of Senti Biosciences Inc (SNTI)
Compared to the last year’s volume of 0.53 million, its volume of 0.46 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 8.60%.
During the past 100 days, Senti Biosciences Inc’s (SNTI) raw stochastic average was set at 1.15%, which indicates a significant increase from 1.15% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.2232 in the past 14 days, which was higher than the 0.1496 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.8553, while its 200-day Moving Average is $2.3186. Nevertheless, the first resistance level for the watch stands at $1.2200 in the near term. At $1.2800, the stock is likely to face the second major resistance level. The third major resistance level sits at $1.3200. If the price goes on to break the first support level at $1.1200, it is likely to go to the next support level at $1.0800. Now, if the price goes above the second support level, the third support stands at $1.0200.
Senti Biosciences Inc (NASDAQ: SNTI) Key Stats
With a market capitalization of 30.49 million, the company has a total of 26,291K Shares Outstanding. Currently, annual sales are 0 K while annual income is -52,790 K. The company’s previous quarter sales were 0 K while its latest quarter income was -18,130 K.
